-
公开(公告)号:DE69821009T2
公开(公告)日:2004-11-18
申请号:DE69821009
申请日:1998-09-01
Applicant: ABBOTT LAB
Inventor: OR SUN , CLARK F , CHU T , PLATTNER J
IPC: A61K31/7042 , A61K31/7048 , A61P31/04 , C07H17/08 , A61K31/70
Abstract: Novel multicyclic erythromycin compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula (I) (II), (III), compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.
-
公开(公告)号:DE69132348T2
公开(公告)日:2001-03-15
申请号:DE69132348
申请日:1991-05-01
Applicant: ABBOTT LAB
Inventor: CHU T , LEE M , LI QUN , COOPER S , PLATTNER J
IPC: A61K31/435 , A61K31/47 , A61K31/505 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/68 , C07D455/02 , C07D471/04 , C07D471/08 , C07D491/10 , C07D491/16 , C07D495/16 , C07D519/00 , C07K5/06 , A61K31/495 , C07D471/16
-
公开(公告)号:DE69132348D1
公开(公告)日:2000-09-07
申请号:DE69132348
申请日:1991-05-01
Applicant: ABBOTT LAB
Inventor: CHU T , LEE M , LI QUN , COOPER S , PLATTNER J
IPC: A61K31/435 , A61K31/47 , A61K31/505 , A61K31/535 , A61K31/54 , A61K38/00 , A61P31/04 , C07D213/68 , C07D455/02 , C07D471/04 , C07D471/08 , C07D491/10 , C07D491/16 , C07D495/16 , C07D519/00 , C07K5/06 , A61K31/495 , C07D471/16
-
公开(公告)号:ZA80371B
公开(公告)日:1981-03-25
申请号:ZA80371
申请日:1980-01-22
Applicant: ABBOTT LAB
Inventor: HERRIN T , VOSS H , PLATTNER J
IPC: C07F9/40 , C12Q1/46 , G01N33/532 , G01N33/542 , G01N
Abstract: The present invention encompasses a method for determining ligands in test samples comprising intermixing with the test sample a ligand analog-irreversible enzyme inhibitor conjugate and a binding protein bindable to the ligand and the ligand analog-irreversible enzyme inhibitor conjugate and wherein the amount of ligand analog-irreversible enzyme inhibitor conjugate bound by the binding protein is related to the amount of ligand in the test sample, said binding protein inactivating the irreversible enzyme inhibitor when bound to the ligand analog portion of the conjugate; intermixing an enzyme which is irreversibly inhibited by the ligand analog-irreversible enzyme inhibitor conjugate unbound by the binding protein; and intermixing substrate to the enzyme and monitoring the enzyme substrate reaction. The invention also includes ligand analog-irreversible enzyme inhibitor conjugates useful as reagents in practicing the method. Methods and reagents of the present are particularly useful in determining drugs, hormones, and the like in biological fluids.
-
公开(公告)号:BE881557A
公开(公告)日:1980-08-05
申请号:BE199272
申请日:1980-02-05
Applicant: ABBOTT LAB
Inventor: PLATTNER J , VOSS H , HERRIN T
IPC: C07F9/40 , C12Q1/46 , G01N33/532 , G01N33/542 , C12Q
-
-
-
-